[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351552-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351552-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","direct-oral-anticoagulants-vs-lmwh-for-cancer-associated-thrombosis-updated-evidence-on-bleeding-risk-recurrence-and-patient-reported-outcomes-a-systematic-review","Direct oral anticoagulants vs LMWH for cancer-associated thrombosis - updated evidence on bleeding risk, recurrence and patient-reported outcomes - A systematic review","","Cancer-associated thrombosis (CAT) increases the risk of dangerous blood clots, and while direct oral anticoagulants (DOACs) are considered for CAT, comparative evidence versus low molecular weight heparin (LMWH) remains limited. This systematic review compares efficacy, bleeding risk, recurrence, and patient-reported outcomes across cancer types. Searches followed PRISMA 2009 and included studies from 2003–2024. Across 29 studies (21,371 patients), recurrence rates were broadly similar, while bleeding risk varied by cancer subtype and DOACs showed higher satisfaction and quality-of-life indicators.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/direct-oral-anticoagulants-vs-lmwh-for-cancer-associated-thrombosis-updated-evidence-on-bleeding-risk-recurrence-and-patient-reported-outcomes-a-systematic-review/351552/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/direct-oral-anticoagulants-vs-lmwh-for-cancer-associated-thrombosis-updated-evidence-on-bleeding-risk-recurrence-and-patient-reported-outcomes-a-systematic-review/351552.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this systematic review?","Question",{"text":63,"@type":64},"To compare the efficacy, bleeding risks, recurrence rate, and patient-reported outcomes of DOACs versus LMWH in cancer-associated thrombosis across different cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies selected and what time period was covered?",{"text":68,"@type":64},"The review followed PRISMA 2009 and searched biomedical databases including PubMed, Scopus, and Cochrane for publications from January 1, 2003 to December 31, 2024.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the review find about VTE recurrence and major bleeding?",{"text":72,"@type":64},"VTE recurrence rates between DOAC and LMWH were similar in major trials, while bleeding risk differed by cancer subtype, with higher significant bleeding reported for certain cancer groups when using DOACs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351552,1790211365,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","| W | J | M | World Journal of\u003Cbr>Methodology |\n| --- | --- | --- | --- |\n| Submit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Methodol 2026 June 20; 16(2): 110380\u003Cbr>DOI: 10.5662/wjm.v16.i2.110380 ISSN 2222-0682 (online) |  |  |  |\n| \u003Cbr>SYSTEMATIC REVIEWS |  |  |  |\n| Direct oral anticoagulants vs LMWH for cancer-associated thrombosis-updated evidence on bleeding risk, recurrence and patient-reported outcomes: A systematic review\u003Cbr>Duaa Asad, Ahris Abid, Muhammad Bari Hassan, Munesh Kumar Nenwani, Sunil Dev, Sanjeet Kumar, Fnu Sapna, Payal Bai, Sadia Siddique, Inshal Jawed, Farah Alam, Farah Abdul Razzaq, Favour C Mekowulu, Shafaq Jabeen, Agha MW Mirza |  |  |  |\n\nPeer review: Externally peer reviewed.  \nPeer-review model: Single blind Peer-review report’s classification Scientific quality: Grade B, Grade B, Grade B, Grade C  \nNovelty: Grade B, Grade B, Grade C, Grade C  \nCreativity or innovation: Grade B, Grade B, Grade C, Grade C Scientific significance: Grade B, Grade B, Grade C, Grade C  \nP-Reviewer: Bouayad A, MD, Associate Professor, Morocco; Feng SM, MD, Chief Physician, Professor, China; Shareef LG, PhD, Chief Pharmacist, Lecturer, Iraq Received: June 6, 2025  \nRevised: July 7, 2025  \nAccepted: October 21, 2025  \nPublished online: June 20, 2026  \nProcessing time: 322 Days and 13.2 Hours  \nCopyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons AttributionNonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.  \nDuaa Asad, Department of Medicine, Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3 LY, United Kingdom  \nAhris Abid, Department of Medicine, Peterborough City Hospital, North West Anglia NHS Foundation Trust, Peterborough PE3 9GZ, United Kingdom  \nMuhammad Bari Hassan, Munesh Kumar Nenwani, Fnu Sapna, Payal Bai, Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro 76090, Sindh, Pakistan  \nSunil Dev, Department of Medicine, Liaquat National Hospital and Medical College, Karachi 74800, Sindh, Pakistan  \nSanjeet Kumar, Department of Medicine, Bilawal Medical College, Affiliated with Liaquat University of Medical and Health Sciences, Jamshoro 76090, Sindh, Pakistan  \nSadia Siddique, Department of Medicine, Faisalabad Medical University, Faisalabad 37610, Punjab, Pakistan  \nInshal Jawed, Department of Medicine, Dow University of Health Sciences, Karachi 75350, Sindh, Pakistan  \nFarah Alam, Department of Medicine, DOW Medical College, Karachi 75280, Sindh, Pakistan Farah Abdul Razzaq, Department of Medicine, Civil Hospital, Karachi 74000, Sindh, Pakistan Favour C Mekowulu, Department of Medicine, Specialist practice for Cardiology and Pulmonology Eggenfelden, Eggenfelden 84307, Bavaria, Germany  \nShafaq Jabeen, Department of Medicine, Karachi Dental and Medical College, Karachi 74700, Sindh, Pakistan  \nAgha MW Mirza, Department of Medicine, Jinnah Medical and Dental College, Karachi 74800, Sindh, Pakistan  \nORCID number: Inshal Jawed 0009-0000-8420-9669.  \nCo-first authors: Duaa Asad and Ahris Abid.  \n [https://dx.doi.org/10.5662/wjm.v16.i2.110380](https://dx.doi.org/10.5662/wjm.v16.i2.110380) 1 June 20, 2026  Volume 16  Issue 2   \nAsad D et al. DOACs vs LMWH in cancer-associated thrombosis  \nCorresponding author: Inshal Jawed, Chief Physician, Senior Researcher, Department of Medicine, Dow University of Health Sciences, Baba-e-urdu Karachi, Karachi 75350, Sindh, [Pakistan.](Pakistan. inshaljwd@gmail.com)[ inshaljwd@gmail.com](Pakistan. inshaljwd@gmail.com)  \nAbstract  \nBACKGROUND  \nCancer increases the risk of developing dangerous and sometimes deadly blood clots, which are known as cancer-associated thrombosis (CAT) . While direct oral anticoagulants (DOACs) can be considered for CAT, evidence is limited regarding their use in comparison to low molecular weight hepa","cbCaivRGMWAyJOfF","https://ap.wps.com/l/cbCaivRGMWAyJOfF","pdf",638657,16,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the main objective of this systematic review?\",\"answer\":\"To compare the efficacy, bleeding risks, recurrence rate, and patient-reported outcomes of DOACs versus LMWH in cancer-associated thrombosis across different cancer types.\"},{\"question\":\"How were studies selected and what time period was covered?\",\"answer\":\"The review followed PRISMA 2009 and searched biomedical databases including PubMed, Scopus, and Cochrane for publications from January 1, 2003 to December 31, 2024.\"},{\"question\":\"What did the review find about VTE recurrence and major bleeding?\",\"answer\":\"VTE recurrence rates between DOAC and LMWH were similar in major trials, while bleeding risk differed by cancer subtype, with higher significant bleeding reported for certain cancer groups when using DOACs.\"}]","Direct oral anticoagulants vs LMWH for cancer-associated thrombosis - updated evidence on bleeding risk, recurrence and patient-reported outcomes - A systematic review | PDF",1790094683,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a2c0431a2f2c701ae72d4cc5e448254.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0883795ff7576d9087220b5bcc7bac05.webp",982,1389,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84c4f266f80971b7ab0fc9f72c4a8831.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fc0eba2d3d373742b3bcff426f4a99f.webp",980,1386]